Le Lézard
Classified in: Health, Covid-19 virus
Subjects: PSF, CFG

Government of Canada supports wastewater monitoring for COVID-19 in Atlantic Canada


CHARLOTTETOWN, PEI, Jan. 17, 2023 /CNW/ - Throughout the COVID-19 pandemic, the Government of Canada has taken a comprehensive and prudent approach to managing the virus, with measures and actions informed by available data, operational considerations, scientific evidence, and monitoring of the epidemiological situation and best practices both in Canada and internationally.

Today, the Honourable Jean-Yves Duclos, Minister of Health, visited the Atlantic Veterinary College at the University of Prince Edward Island, which will receive $1.5 million from the Public Health Agency of Canada (PHAC) to enhance COVID-19 wastewater testing capacity for the Atlantic provinces.

This project supports the National Wastewater Surveillance Program by increasing the reach of monitoring and allows COVID-19 testing to be completed quickly in the region, without the need to ship the samples to Canada's National Microbiology Laboratory (NML) in Winnipeg, Manitoba. Wastewater data is an important early warning sign for public health action and decisions for the benefit of communities in Atlantic Canada.

Wastewater monitoring has been essential in COVID-19 monitoring and is one of the key tools guiding the future of public health surveillance. People infected with COVID-19 can shed the virus through their stool, even if they do not have any symptoms. Testing a community's sewage (wastewater) can help determine if COVID-19 is increasing or decreasing in a community and provides information on the variants circulating within a community. People can also use wastewater trend data to make decisions about personal health measures when going out into their community.  

PHAC scientists, along with their Canadian academic and provincial/territorial partners, are leading the way on wastewater surveillance based on its growing use during the COVID-19 pandemic. This knowledge, combined with PHAC's work with provincial, territorial, municipal, and Indigenous governments to establish a strong network of wastewater testing sites across Canada, has also helped scientists study the presence of other diseases in wastewater, including antimicrobial resistant organisms, mpox (monkeypox), and poliovirus.

The Government of Canada has committed $28.1 million since May 2020 to establish, expand and enhance the pan-Canadian wastewater surveillance program. It provides an innovative and straightforward approach that enables efficient monitoring of a population (or community) for early detection and trending of pathogen activity.

Quotes

"Wastewater monitoring is the future of public health surveillance for infectious diseases in Canada. It is an innovative tool that currently assists in determining the levels of COVID-19 in communities and provides an early warning to public health authorities of
COVID-19 variants. The funding announced today will increase the range and speed of wastewater testing results for Atlantic Canadians resulting in a rapid and cost-effective approach for early detection of outbreaks and surges."

The Honourable Jean-Yves Duclos
Minister of Health

"The University of Prince Edward Island is pleased that expertise at the Atlantic Veterinary College's Diagnostic Services department will be harnessed to aid in the monitoring of COVID-19 and other pathogens of public health significance in the Atlantic region. We are grateful for this funding from the Public Health Agency of Canada, allowing us to be part of this important pan-Canadian wastewater surveillance network."

Dr. Greg Keefe
President and Vice-Chancellor (Interim)
University of Prince Edward Island

"The health of Atlantic Canadians is always a priority. With the state-of-the-art equipment and expertise at UPEI and AVC, this funding will help PHAC quickly identify and react to current and future abnormalities in the wastewater system. This investment also underscores the value and significance of these great PEI institutions and the depth of talent that distinguishes them."

Sean Casey
Member of Parliament for Charlottetown 

Quick Facts

SOURCE Public Health Agency of Canada


These press releases may also interest you

at 08:05
Gilead Sciences, Inc. today announced the U.S. Food and Drug Administration (FDA) approved an updated label with additional data reinforcing the safety and efficacy profile of Biktarvy® (bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide...

at 08:05
Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (MDNAF: OTCQB), a clinical-stage immunotherapy company focused on the development of engineered cytokines, today announced a CA$20 million investment by RA Capital Management, a multi-stage...

at 08:02
Sobi® today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has issued a positive opinion recommending approval of efanesoctocog alfa, for the treatment and prevention of bleeds and perioperative...

at 08:00
Citius Pharmaceuticals Inc. ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, today announced that it has entered into definitive...

at 08:00
Florida Cancer Specialists & Research Institute, LLC (FCS) President & Managing Physician Lucio N. Gordan, MD will serve as a panelist at the 2024 Oncology Fellows & Faculty Forum in Miami, sponsored by PrecisCa and the Community Oncology Alliance...

at 08:00
Renibus Therapeutics® ("Renibus"), a clinical-stage biopharmaceutical company focusing on the prevention and treatment of cardio, renal and metabolic diseases, today announced its participation at two prestigious medical conferences: the American...



News published on and distributed by: